Investor Overview

May 2021

NASDAQ:SMED

2

Safe Harbor Statement

These slides contain certain forward-looking statements and information relating to theCompany and its subsidiaries that are based on the beliefs of the Company’s management aswell as assumptions made by and information currently available to the Company’smanagement. When used in these slides, the words “may,” “position,” “plan,” “potential,”“continue,” “anticipate,” “believe,” “expect,” “estimate,” “project” and “intend” and words orphrases of similar import, as they relate to the Company or its subsidiaries or Companymanagement, are intended to identify forward-looking statements. Such statements reflectknown and unknown risks, uncertainties and assumptions related to certain factors, includingwithout limitation, competitive factors, general economic conditions, customer relations,relationships with vendors, governmental regulation and supervision, seasonality, distributionnetworks, product introductions and acceptance, technological change, changes in industrypractices, onetime events and other factors described herein including the impact of thecoronavirus COVID-19 (“COVID-19”) pandemic on our operations and financial results. Basedupon changing conditions, should any one or more of these risks or uncertainties materialize, orshould any underlying assumptions prove incorrect, actual results may vary materially fromthose described herein as anticipated, believed, estimated, expected or intended.Consequently, no forward-looking statements can be guaranteed. When considering theseforward-looking statements, you should keep in mind the risk factors and other cautionarystatements in the Company’s Annual Report on Form 10-K. Actual results may vary materially.You are cautioned not to place undue reliance on any forward-looking statements. You shouldalso understand that it is not possible to predict or identify all such factors and as such shouldnot consider the preceding list or the risk factors to be a complete list of all potential risks anduncertainties. The Company does not intend to update these forward-looking statements.

• COMPANY OVERVIEW

• MEDICAL WASTE

SOLUTIONS

• UNUSED MEDICATIONS

• FINANCIAL REVIEW

AGENDA

3

A Leader In Medical Waste Solutions

Serving Two Billion Dollar Markets

Medical Waste for Small to Medium Sized Generators

10.6% 5-YEAR CAGR; STRONG BALANCE SHEET

72% of Revenue*

10% Revenue Growth*

18% of Revenue*

32% Revenue Growth*

• Full Year Ended 6.30.20; Medical Waste for Small and Medium Sized Generators

includes Mailback and Route Based

4

Unused Medications

Immunization Related Opportunities

• COVID-19 Vaccines for Adults (February 2021)

• COVID-19 Vaccines for Adolescents (May 2021)

• Seasonal Flu Vaccines (Fall 2021)

• COVID-19 Vaccines for Children (September 2021)

• COVID-19 related Boosters (Fall 2021- Spring 2022)

• Future Coronavirus Vaccines

5

Playing a Key Role in COVID-19 Vaccine Programs in

Retail and Long-Term Care Settings

MarketMarket

Size

Market

Growth

Rate

Market

Position

(U.S.)

Market

Penetration

Small-

Medium

Quantity

Medical

Waste

>$1B ~5.5% 2nd <4%

Unused

Medication >$1B ~4.2% 1st <1%

6

*

*Source: Kaiser Family Foundation Analysis of National Health Expenditure from Centers for Medicare & Medicaid

Services, Office of the Actuary, National Health Statistics Group (Accessed on December 13, 2017)

Well-Positioned In Attractive Markets

7

Growing End Market Opportunity

Addressable Market Size

$1.0B*

$2.0B*

Founding of

Company

~3 Years Ago

Today

Comprehensive

Medical Waste:

Mailback

+

Pick-Up Service

(Company Owned)

+

Unused

Medication

Comprehensive

Medical Waste:

Mailback

+

Pick-Up Service

(Company Owned)Medical Waste:

Mailback

$0.25B - $0.5B*

*

8

Improving Revenue Mix% of Total Revenue

Route-Based20%

Unused Medication

18%

Mailback52%

2020 Route-Based

1%

Unused Medication

6%

Mailback93%

2013

9

MEDICAL WASTE SOLUTION

Everything But The Hospital

10

Serving All Small to Medium Quantity Generator Markets

* Professional includes dentists, veterinarians, clinics, physician groups, urgent care facilities, ambulatory surgical centers, labs, dialysis centers and other healthcare facilities.

Point-of-Care Shifting Towards Sharps’ Core Customers

Aging

Population

Traditional

Healthcare Setting

Professional

Market*

Retail

Pharmacies

Home

Health Care

Long-Term Care

Small to Medium Setting

Cost Pressure

11

Market Landscape: Small & Medium Quantity Generators

$0

$200

$400

$600

$800

$1,000

Local/Regional National/Full-Service

Revenues (in millions)

Market Opportunity

200+ Small Private

Local & Regional Providers

+

Well Positioned to Grow Organically and Through Acquisition

No Other

Providers

12

Industry-Leading Mailback Offering

▪ Flagship solution available for all small to medium quantity

generators throughout the United States.

▪ Quickly scalable to meet market demands.

▪ Comprehensive solution for collecting sharps and other

small quantities of medical waste.

▪ Available in a vast array of sizes

and configurations to meet

market needs.

▪ Provides flexibility and expands

offering when blended with route-

based service.

13

Strategic Expansion Of Route-Based Offering

▪ Extending our route-based reach through acquisitions in new geographic areas, tuck-in opportunities in current service areas and organic growth.

▪ Serving 15,400 direct route-based customers at 3.31.21

▪ Expanded footprint complements mailback offering to provide versatile solution options; enables engagement of larger customers with extensive locations.

▪ Provides more predictable revenue stream.

▪ Focused route-based strategy in densely populated areas.

▪ Strengthens our leadership in healthcare and retail markets.

▪ Direct service in 37 states; 80% of the population.

14

Service to 37 States & 80% of U.S. Population

Route-based service (via network)

Company owned route-based

Evolution Of National Footprint

15

State-of-the-Art Treatment Facilities

Carthage, TX

▪ 1 of 10 permitted incinerators for medical waste and

unused medications in the U.S.

▪ 2 autoclaves

Nesquehoning, PA

▪ 2 Autoclaves

Treating Sharps-Collected Waste

16

Significant Capacity Available To Support Growth At Treatment Facilities

Expanded Processing Capacity to 27 Million Pounds Per Year From

10 million a year ago

Current

Shifts

1

2

3

Shifts

1

2

3

Total Capacity

• Running two

autoclaves with

one shift each

• Capacity to run 3

shifts each

• Footprint is now

40,000 square feet

for treatment

Current

Shifts

1

2

3

Shifts

1

2

3

Total Capacity

Carthage, TX Nesquehoning, PA

• Running 1.5 shifts

for autoclaves and

one shift for

incinerator

• Capacity to run 3

shifts each

• Increased footprint

from 13,000 square

feet to 30,500

square feet

• August 2020: Added

second autoclave to

expand capacity

Autoclave

IncineratorAutoclave

Autoclave

17

Shift To Full-Service

Route-based28%

Mailback72%

2020

Mailback 99%

Route-based 1%

2013

Route-based as Percentage of Medical Waste Revenue

18

Attractive Segments In Small To Medium Quantity Generator Markets; Addressing Medical Waste Only

2. Assumes about 45% of adults received flu shots and about 40% of U.S. flu shots for adults administered in retail pharmacies, per industry sources

1. Average projected growth rates of physician, dental, and veterinary spending

3. Over the flu seasons from 2011-2020, Sharps saw growth in seven years of 10% to 36%, including a 25% increase in 2020, and declines in three years of 13% to 17%.

Market Market Size

Market

Growth

Rate

Current

Penetration

Professional $727M 5%¹ 2%

Long-Term Care $85M 6% 4%

Home Health Care $100M 7% 10%

Retail Pharmacy $15.6M² 20-25%³ 71%

(FY 2020)

4. Excludes revenues associated with unused medications solutions

4

$727M

Market

Opportunity

Professional Market

• Dental

• Veterinarian

• Physicians

• Labs

• Urgent Care

• Surgery Centers

• Dialysis Centers

• Funeral Homes

19

800,000

Professional

Offices (U.S.)

20

Long-Term Care Market

*National Institute on Aging

Market Opportunity

$85M

Total

Addressable

Market

1 in 5 Americans

Age 65+

Customers

20

21

Retail Pharmacy Market

We serve 69% of retail immunizing pharmacies

*2016 and 2018 per Centers for Disease Control

and Prevention, November 2018. 2019 and 2020

per industry sources.

Market Opportunity

Percentage of adults receiving flu

shots in the retail setting:

24%

2016

32%

2018

21

40%

2019

Retail

Pharmacies

Expect Up

to 50% in

2020/2021

22

COVID-19 Operational Update

Providing Uninterrupted Essential Medical Waste Solutions to Healthcare Customers

▪ Increased route-based drivers, plant & operations personnel by 10% to ensure operations wouldn’t be adversely impacted by potential employee absences

▪ Temporarily increased pay for frontline operations through June 2020

▪ Built mailback inventory of 300,000 at 1.1.21; ability to manufacture up to 1.6 million units by end of calendar 2021

Increased medical waste processing capacity from 10 million to 27 million pounds

▪ Carthage facility: added new, larger autoclave and expanded footprint

▪ Pennsylvania facility: Added second autoclave; secured larger warehouse and distribution facility to store and distribute larger volumes of medical waste mailbacks

23

UNUSED MEDICATIONS

24

Unused Medications Market Opportunity Growing Concern Given Opioid Epidemic and Accidental Overdoses

~250M lbs. Unused Medication

Waste Per Year

$1BMarket

Opportunity

Sharps Unused Medication Revenue increased from

$1.3 million in 2014 to $9.2 million in 2020

25

Unused Medication & Controlled Substances: MedSafe

Solution Designed to Meet or Exceed DEA Proper Disposal Guidelines:

Helping Address the Opioid Abuse Crisis

Customers

Pharmacies (retail and hospital)

Long-term care facilities

Government & local law enforcement

Narcotic treatment programs

26

Growing Installed Base of MedSafe Creates Recurring Revenue Opportunity

Installs: 876

Returned Liners: 5,583

(3/31/17)

Installs: 2,173

Returned Liners: 13,182

(3/31/18)

Installs: 5,950

Returned Liners: 75,700(3/31/21)

Installs: 3,200

Returned Liners: 28,500

(3/31/19)

Installs: 4,700

Returned Liners: 50,000+

(3/31/20)

27

Solution Designed to Meet or Exceed DEA Proper Disposal Guidelines:

▪ TakeAway Medication Recovery

System™ envelopes for proper

mailback disposal of unused

medication, including controlled

substances, from ultimate users

Unused Medication & Controlled Substances: Takeaway Envelopes

Customers

Retail pharmacies

Long-term care

VA & Military

Note: Envelope image shown above is for marketing purposes only. The actual envelope is not branded as

to meet the requirements of the Disposal Act (nondescript packaging).

~4.2M TakeAway Medication Recovery

System™ envelopes sold since 2009

28

FINANCIAL REVIEW

74.6%

2.8%

8.6%

14.0%

52.0%

20.3%

17.9%

9.8%

FY 2015 Revenue $30.9 million

FY 2020 Revenue $51.1 million

29

Breakdown By Solution

Mailback

Route-Based

Unused Medications

Other

Home Health Care19%

Retail30%

Pharmaceutical Manufacturer

9%

Long-term Care6%

Other2%

Professional29%

Government4%

Environmental1%

Home Health Care55%

Retail8%

Pharmaceutical Manufacturer

7%

Long-term Care9%

Other15%

Professional 6%

FY 2008 Billings $13.2 million

FY 2020 Billings$53.0 million

30

Increased Revenue Diversity By Market

31

Billings By Market & Solution

Three Months Ended March 31,

2021 % Total 2020 $ Change %

BILLINGS BY Solution:

Mailbacks $ 24,373 78.5 % $ 4,614 $ 19,759 428.2 %

Route-Based Pickup 3,597 11.6 % 2,625 972 37.0 %

Unused Medications 2,078 6.7 % 2,111 (33) (1.6) %

Third Party Treatment 76 0.2 % 38 38 100.0 %

Other 884 3.0 % 938 (54) (5.8) %

Total Billings By Solution $ 31,008 100.0% $ 10,326 $ 20,682 200.3 %

Three Months Ended March 31,

2021 % Total 2020 $ Change %

BILLINGS BY MARKET:

Retail $ 21,714 70.0 % $ 2,314 $ 19,400 838.4 %

Professional 4,606 14.9 % 3,885 721 18.6 %

Home Health Care 2,299 7.4 % 1,663 636 38.2 %

Pharmaceutical Manufacturer 567 1.8 % 857 (290) (33.8) %

Long-Term Care 973 3.1 % 758 215 28.4 %

Government 642 2.1 % 571 71 12.4 %

Environmental 76 0.2 % 38 38 100.0 %

Other 131 0.5 % 240 (109) (45.4) %

Subtotal $ 31,008 100.0% $ 10,326 $ 20,682 200.3 %

GAAP Adjustment * (3,480) 88 (3,568)

Revenue Reported $ 27,528 $ 10,414 $ 17,114 164.3 %

*Represents the net impact of the revenue recognition adjustments to arrive at reported GAAP revenue. Customer

billings include all invoiced amounts for products shipped or services rendered during the period reported. GAAP

revenue includes customer billings as well as numerous adjustments necessary to reflect, (i) the deferral of a portion

of current period sales, (ii) recognition of certain revenue associated with product returned for treatment and

destruction and (iii) provisions for certain product returns and discounts to customers which are accounted for as

reductions in sales in the same period the related sales are recorded.

32

Billings By Market & Solution

Nine Months Ended March 31,

2021 % Total 2020 $ Change %

BILLINGS BY Solution:

Mailbacks $ 42,719 67.9% $ 21,280 $ 21,439 100.7 %

Route-Based Pickup 10,244 16.3% 7,762 2,482 32.0 %

Unused Medications 6,152 9.8% 6,815 (663) (9.7 )%

Third Party Treatment 390 0.6% 123 267 217.1 %

Other 3,397 5.4% 3,495 (98) (2.8 )%

Total Billings By Solution $ 62,902 100.0% $ 39,475 $ 23,427 59.3 %

Nine Months Ended March 31,

2021 % Total 2020 $ Change %

BILLINGS BY MARKET:

Retail $ 31,500 50.1 % $ 10,674 $ 20,826 195.1 %

Professional 13,277 21.1 % 12,385 892 7.2 %

Home Health Care 7,479 11.9 % 7,586 (107) (1.4) %

Pharmaceutical Manufacturer 4,808 7.6 % 4,068 740 18.2 %

Long-Term Care 3,342 5.3 % 2,063 1,279 62.0 %

Government 1,654 2.6 % 1,824 (170) (9.3) %

Environmental 390 0.6 % 123 267 217.1 %

Other 452 0.8 % 752 (300) (39.9) %

Subtotal $ 62,902 100.0% $ 39,475 $ 23,427 59.3 %

GAAP Adjustment * (5,212) (897) (4,315)

Revenue Reported $ 57,690 $ 38,578 $ 19,112 49.5 %

*Represents the net impact of the revenue recognition adjustments to arrive at reported GAAP revenue. Customer

billings include all invoiced amounts for products shipped or services rendered during the period reported. GAAP

revenue includes customer billings as well as numerous adjustments necessary to reflect, (i) the deferral of a portion

of current period sales, (ii) recognition of certain revenue associated with product returned for treatment and

destruction and (iii) provisions for certain product returns and discounts to customers which are accounted for as

reductions in sales in the same period the related sales are recorded.

33

$21.5

$26.6

$30.9$33.4

$38.2$40.1

$44.3$51.1

$-

$10

$20

$30

$40

$50

$60

FY 2013 FY 2014 FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 FY2020

($ in millions)

Steady Annual Revenue Growth:

10.6 % 5-year CAGR

34

Select Financials

(In thousands,

excluding per share

data)

Three Months

Ended

March 31,

2021

Three Months

Ended

March 31,

2020

Nine Months

Ended

March 31,

2021

Nine Months

Ended

March 31,

2020

Revenue $27,528 $10,414 $57,690 $38,578

Gross Margin 48.7% 21.3% 39.3% 30.0%

SG&A Expense $4,181 $3,600 $11,725 $10,718

Operating Margin32.7% (15.2)% 17.9% 0.7%

Net Income $6,850 $(1,556) $7,785 $100

Net Income Per Share $0.41 $(0.10) $0.47 $0.01

EBITDA $9,550 $(1,190) $11,795 $1,450

EBITDA Margin 34.7% (11.4)% 20.4% 3.8%

Strong Balance Sheet: $20.7M in Working Capital

35

Attractive Business Model

Significant Operating Leverage

▪ Costs are relatively fixed• Operating infrastructure in place to grow 2-3X

▪ 45% - 50% gross margins on incremental revenues▪ 10%+ SG&A increase on incremental revenues

High Recurring Revenue

▪ Recurring revenue model; high customer retention rates• Expect strong flu immunization season potentially followed by COVID-19

immunization effort and anticipated growth in the long-term care, home healthcare and professional markets

Attractive Alternative For Marketplace

▪ Competitive contract pricing and terms

▪ Customizable solution

▪ Nationwide coverage

▪ Route-based footprint expansion to 37 states or 80% of population increases new

prospect pipeline of larger small and medium quantity generators

Thank You

NASDAQ:SMED